Melatonin for heart health in midlife women
Part of Heart & circulation clinical trials.
This study tests whether melatonin can help improve heart health in midlife women with high blood pressure. It involves taking a melatonin pill or placebo for several weeks and checking blood pressure and other health markers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 40 and 55 years old.
- You still have your uterus and at least one ovary.
- You have high blood pressure (or take medicine for it).
- You are not taking any sleep aids or melatonin supplements.
- You do not work night shifts and do not use tobacco or nicotine products.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how menopausal hormone therapy might affect the heart's pumping ability. It may help women who are naturally entering menopause understand if hormone therapy can protect their heart health.
This study tests whether taking a melatonin supplement every night for two years reduces the risk of heart problems and cancer in older adults. If you are generally healthy and between 60 and 74, you may be able to join.
This study tests whether taking 5 mg of melatonin can improve thinking and brain health over time in older adults with early, mild symptoms. You may help researchers learn which brain changes and measures improve with melatonin.
This trial tests if adding melatonin to standard heart medication helps protect the heart muscle in people with cardiomyopathy. If you are stable on your current heart meds, you may be able to join.
This study tests whether adding melatonin to standard heart failure treatment helps women with peripartum cardiomyopathy recover heart function and reduce inflammation. It may offer a simple, well-tolerated option to support heart healing after pregnancy.
This trial tests a new inhaled form of melatonin to help adults aged 55 and older with insomnia fall asleep faster. It compares the inhaled melatonin to a placebo to see if it improves sleep and is safe.
Hear when a new Perimenopause trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.